Which therapy either prolotherapy or platelet rich plasma is better in rotator cuff disease
Not Applicable
- Conditions
- Health Condition 1: M65-M67- Disorders of synovium and tendon
- Registration Number
- CTRI/2020/03/023748
- Lead Sponsor
- ADY HARDINGE MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adults( >18years) with chronic shoulder pain for >6 months
Average Numerical Pain Rating Scale (NRS) > 4
Exclusion Criteria
Any corticosteroid injection within last 8 weeks
Complete Rotator cuff tear
Patients having chronic pain due to other diseases like malignancy, cervical radicular pain, stroke, uncontrolled diabetes and having coagulopathies, skin infection over shoulder area and allergy to local anesthetics
Any shoulder surgery or arthroscopy of the affected shoulder within the past one year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Mean Numerical Pain Rating Scale(NRS)score in both the groups group P(Prolotherapy) and group R (PRP therapy) at 1 month 3 month and 6 month follow upTimepoint: 1 month <br/ ><br>3 month <br/ ><br>6 month
- Secondary Outcome Measures
Name Time Method Shoulder Pain and Disability Index (SPADI) at 1 month 3 month and 6 month <br/ ><br>Proportion of patients with Post injection complications (infection or hematoma) at the site of injection in both the therapiesTimepoint: 1 month <br/ ><br>3 month <br/ ><br>6 month